Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.500 | None | 0.963 | 26 | 1 | 1998 | 2019 | ||||||||
|
steroid 5 alpha-reductase 2 | 0.564 | 0.615 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2003 | 2016 | |||||||||
|
ectodysplasin A2 receptor | 0.736 | 0.423 | 5.5E-04 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2008 | 2012 | ||||||||
|
histone deacetylase 9 | 0.439 | 0.846 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2011 | 2017 | ||||||||
|
dickkopf WNT signaling pathway inhibitor 2 | 0.599 | 0.692 | 0.75 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2016 | 2017 | ||||||||
|
fibroblast growth factor 5 | 0.641 | 0.500 | 2.1E-10 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2016 | 2017 | ||||||||
|
aspartylglucosaminidase | 0.570 | 0.808 | 4.3E-06 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2009 | 2013 | ||||||||
|
dickkopf WNT signaling pathway inhibitor 1 | 0.439 | 0.885 | 0.17 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2008 | 2019 | ||||||||
|
kallikrein related peptidase 3 | 0.443 | 0.885 | 4.4E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
gamma-glutamylcyclotransferase | 0.552 | 0.808 | 1.4E-04 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2005 | 2015 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2018 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2011 | 2020 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2018 | ||||||||
|
prion protein | 0.445 | 0.923 | 6.3E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
microRNA 410 | 0.575 | 0.692 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
sex hormone binding globulin | 0.438 | 0.808 | 1.3E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
steroid 5 alpha-reductase 1 | 0.631 | 0.538 | 1.2E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
complement component 4 binding protein alpha | 0.556 | 0.846 | 0.46 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
nuclear receptor coactivator 4 | 0.619 | 0.577 | 2.2E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
caspase recruitment domain family member 14 | 0.546 | 0.846 | 1.2E-19 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
peroxiredoxin 2 | 0.474 | 0.885 | 8.7E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 |